# Serum Institute of India Pvt. Ltd. trials: 26 (2026)

ClinicalTrials.gov lists 26 trials with Serum Institute of India Pvt. Ltd. as lead sponsor, 5 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Serum Institute of India Pvt. Ltd.: 26 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/serum-institute-of-india-pvt-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888686 | Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV)... | Serum Institute of India Pvt. Ltd. | Phase 1/2 | Not yet recruiting | Human Papillomavirus Infection | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888686) |
| October 2, 2026 | NCT07855172 | Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus... | Serum Institute of India Pvt. Ltd. | Phase 1/2 | Recruiting | Diptheria Immunization, Tetanus Immunization, Pertussis Immunization, Hepatitis B Immunization, Haemophilus... | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855172) |
| July 7, 2026 | NCT07688369 | Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults | Serum Institute of India Pvt. Ltd. | Phase 1 | Recruiting | Polio Immunity | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07688369) |
| January 30, 2026 | NCT07379151 | Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX... | Serum Institute of India Pvt. Ltd. | Observational | Recruiting | Meningoccocal Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07379151) |
| August 29, 2025 | NCT07147400 | Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults | Serum Institute of India Pvt. Ltd. | Phase 2 | Active not recruiting | Prevention of Malaria Transmission and Clinical Malaria | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07147400) |
| June 8, 2025 | NCT07009847 | An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine | Serum Institute of India Pvt. Ltd. | Observational | Recruiting | Malaria,Falciparum, Morality | 2,308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07009847) |
| July 18, 2024 | NCT06507605 | Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults | Serum Institute of India Pvt. Ltd. | Phase 1 | Completed | Prevention of Malaria Transmission and Clinical Malaria | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06507605) |
| May 14, 2024 | NCT06413121 | Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Diptheria Immunization, Tetanus Immunization, Pertussis Immunization, Hepatitis B Immunization, Haemophilus Influenzae... | 1,557 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06413121) |
| February 28, 2024 | NCT06281119 | Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years | Serum Institute of India Pvt. Ltd. | Phase 3 | Active not recruiting | Human Papillomavirus Infection | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06281119) |
| July 7, 2022 | NCT05447377 | A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants | Serum Institute of India Pvt. Ltd. | Phase 3 | Unknown | Yellow Fever | 2,216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05447377) |
| June 16, 2022 | NCT05421611 | A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Yellow Fever | 1,824 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05421611) |
| December 20, 2021 | NCT05163561 | Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Poliomyelitis | 1,072 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05163561) |
| April 24, 2020 | NCT04358731 | Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity... | Serum Institute of India Pvt. Ltd. | Phase 2/3 | Completed | Vaccine for Meningococcal Disease | 1,640 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04358731) |
| April 17, 2020 | NCT04351685 | Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Mycobacterium Tuberculosis Infection | 6,940 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04351685) |
| July 29, 2019 | NCT04035278 | A Phase 1 Safety Study of Dengusiil in Healthy Adults | Serum Institute of India Pvt. Ltd. | Phase 1 | Completed | Prevention of Dengue Fever | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04035278) |
| May 28, 2019 | NCT03964012 | Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Meningococcal Meningitis | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03964012) |
| March 21, 2019 | NCT03883620 | Safety Study of Dengushield in Healthy Adults | Serum Institute of India Pvt. Ltd. | Phase 1 | Completed | Phase 1, Dengue | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03883620) |
| March 22, 2018 | NCT03474055 | Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With... | Serum Institute of India Pvt. Ltd. | Phase 2/3 | Completed | Rotavirus Gastroenteritis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03474055) |
| September 27, 2017 | NCT03295318 | Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds | Serum Institute of India Pvt. Ltd. | Phase 2 | Completed | Meningitis, Meningococcal | 375 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03295318) |
| May 15, 2017 | NCT03152903 | Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence | Serum Institute of India Pvt. Ltd. | Phase 2/3 | Completed | Prevention of TB Recurrence | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03152903) |
| October 23, 2015 | NCT02584816 | Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Rotavirus Gastroenteritis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02584816) |
| April 6, 2015 | NCT02409095 | Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants | Serum Institute of India Pvt. Ltd. | Phase 4 | Terminated | Immune Response to DTP-HB-Hib Vaccine | 211 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02409095) |
| March 18, 2015 | NCT02391415 | Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa | Serum Institute of India Pvt. Ltd. | Phase 2 | Completed | Tuberculosis | 416 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02391415) |
| October 1, 2014 | NCT02253407 | Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children | Serum Institute of India Pvt. Ltd. | Phase 4 | Completed | Immune Response to MMR Vaccine | 341 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02253407) |
| May 8, 2014 | NCT02133690 | A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants | Serum Institute of India Pvt. Ltd. | Phase 3 | Completed | Rotavirus Gastroenteritis | 7,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02133690) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 2 |
| Phase 2 | 3 |
| Phase 2/3 | 3 |
| Phase 3 | 9 |
| Phase 4 | 2 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Recruiting | 4 |
| Active not recruiting | 2 |
| Unknown | 1 |
| Terminated | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Yellow Fever | 2 |
| Meningitis, Meningococcal | 2 |
| Poliomyelitis | 2 |
| Papillomavirus Infections | 2 |
| Tuberculosis | 2 |
| Malaria, Falciparum | 1 |
| Malaria | 1 |
| Death | 1 |
| Dengue | 1 |
| Recurrence | 1 |
| Gastroenteritis | 1 |
| Diarrhea | 1 |
| Mycoses | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Haitian restaurants in the United States](https://specstream.ai/data/businesses/haitian-restaurants/united-states)
- [Wine wholesalers in the United States](https://specstream.ai/data/businesses/wine-wholesalers/united-states)
- [Land surveyors in the United States](https://specstream.ai/data/businesses/land-surveyors/united-states)
- [B2B secretarial companies in the United States](https://specstream.ai/data/businesses/b2b-secretarial-companies/united-states)
- [Oncology practices in the United States](https://specstream.ai/data/businesses/oncology-practices/united-states)
- [Chinese restaurants in the United States](https://specstream.ai/data/businesses/chinese-restaurants/united-states)
